Bayer Roundup Settlement Approved
A court approved Bayer's $7.25 billion deal to settle Roundup cancer claims.
November 20, 2026 · Updated Nov 20, 8:39pm ET
34%
Left · 3
33%
Center · 3
33%
Right · 3
Pano counted 9 articles from 9 outlets: 34% left-leaning, 33% center and 33% right-leaning. Pano rates the coverage Balanced.
What happened
- A Missouri judge on Friday approved a nationwide settlement under which Bayer will pay up to $7.25 billion to resolve Roundup cancer claims.
- People suing Bayer alleged it should have warned that the weedkiller could cause non-Hodgkin lymphoma, while Bayer denies that Roundup causes cancer.
- The settlement covers Roundup users already diagnosed with non-Hodgkin lymphoma and those diagnosed in future years.
- The approval follows a Supreme Court ruling that barred state-court claims over missing cancer warnings when federal rules do not require them.
- Bayer will pay over two decades, with participants potentially receiving averages ranging from $10,000 to $165,000 depending on their exposure, age at diagnosis and illness severity.
How the left told it
Left-leaning outlets ran reports from Reuters and the Associated Press rather than their own: The Guardian, Boston Globe and PBS NewsHour carried them.
How the right told it
Right-leaning outlets focused on the settlement’s financial and legal stakes. The Washington Examiner highlighted Bayer’s prospect of financial relief from mounting lawsuits and the Supreme Court’s limits on warning-label claims, while also noting elevated lymphoma rates among agricultural workers and the EPA’s position that glyphosate does not cause cancer when used as directed.

Boston Globe
The Hill

PBS NewsHour

Breitbart News

